search
Back to results

Effect of Oxygen Supplementation During Exercise in Chronic Obstructive Pulmonary Disease Patients

Primary Purpose

Chronic Obstructive Pulmonary Disease, Hypoxia

Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Oxygen
Sponsored by
LHL Helse
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Obstructive Pulmonary Disease

Eligibility Criteria

20 Years - 95 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Chronic obstructive pulmonary disease

Exclusion Criteria:

  • No exacerbation
  • No active heart disease

Sites / Locations

  • LHL-klinikkene Glittre

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Supplementary oxygen

Arm Description

Study subjects receive, in randomized order, either supplementary 30% oxygen or air (21% Oxygen) from a gas tight bag

Outcomes

Primary Outcome Measures

Pulmonary ventilation

Secondary Outcome Measures

Dyspnoea
Heart rate
Blood pressure

Full Information

First Posted
April 7, 2014
Last Updated
March 21, 2018
Sponsor
LHL Helse
search

1. Study Identification

Unique Protocol Identification Number
NCT02108925
Brief Title
Effect of Oxygen Supplementation During Exercise in Chronic Obstructive Pulmonary Disease Patients
Official Title
Oxygen Supply and Ventilation During Physical Exercise in Patients With Chronic Obstructive Pulmonary Disease
Study Type
Interventional

2. Study Status

Record Verification Date
March 2018
Overall Recruitment Status
Completed
Study Start Date
April 2014 (undefined)
Primary Completion Date
March 2016 (Actual)
Study Completion Date
March 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
LHL Helse

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The project will test the hypothesis that lung ventilation during exercise is unaffected by oxygen supplementation. In addition, the acute effect of oxygen supplementation on dyspnoea, heart rate and blood pressure will be studied.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Obstructive Pulmonary Disease, Hypoxia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
ParticipantInvestigator
Allocation
N/A
Enrollment
16 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Supplementary oxygen
Arm Type
Experimental
Arm Description
Study subjects receive, in randomized order, either supplementary 30% oxygen or air (21% Oxygen) from a gas tight bag
Intervention Type
Drug
Intervention Name(s)
Oxygen
Intervention Description
supplementary oxygen during exercise
Primary Outcome Measure Information:
Title
Pulmonary ventilation
Time Frame
1 hour
Secondary Outcome Measure Information:
Title
Dyspnoea
Time Frame
1 hour
Title
Heart rate
Time Frame
1 hour
Title
Blood pressure
Time Frame
1 hour

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
95 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Chronic obstructive pulmonary disease Exclusion Criteria: No exacerbation No active heart disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anne Edvardsen, PhD
Organizational Affiliation
LHL Helse
Official's Role
Principal Investigator
Facility Information:
Facility Name
LHL-klinikkene Glittre
City
Hakadal
State/Province
Akershus
ZIP/Postal Code
1485
Country
Norway

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effect of Oxygen Supplementation During Exercise in Chronic Obstructive Pulmonary Disease Patients

We'll reach out to this number within 24 hrs